8‐Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis (original) (raw)
Substituted 4-methylquinolines as a new class of anti-tuberculosis agents
Rahul Jain
2003
View PDFchevron_right
Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones
Stanislav Kafka
European Journal of Medicinal Chemistry, 2017
View PDFchevron_right
Investigating the Activity Spectrum for Ring-Substituted 8-Hydroxyquinolines
Aidan Coffey
Molecules, 2010
View PDFchevron_right
Synthesis and structural–activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents
Rajeshwar Singh
Bioorganic & Medicinal Chemistry Letters, 2004
View PDFchevron_right
Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis
Shailesh Dixit
Bioorganic & Medicinal Chemistry, 2009
View PDFchevron_right
Synthesis and 3D-QSAR Analysis of 2-Chloroquinoline Derivatives as H 37 RV MTB Inhibitors
Ranjan Khunt
Chemical Biology & Drug Design, 2013
View PDFchevron_right
Synthesis, anti-tuberculosis activity and QSAR study of 2,4-diarylquinolines and analogous polycyclic derivatives
Juan Carnevale
Arabian Journal of Chemistry, 2019
View PDFchevron_right
Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials
Parvesh Singh
Bioorganic & Medicinal Chemistry Letters, 2020
View PDFchevron_right
Anti-Mycobacterial Evaluation of 7-Chloro-4-Aminoquinolines and Hologram Quantitative Structure-Activity Relationship (HQSAR) Modeling of Amino-Imino Tautomers
Magaly G Albuquerque
Pharmaceuticals (Basel, Switzerland), 2017
View PDFchevron_right
Design and synthesis of new 3-((7-chloroquinolin-4-yl)amino)thiazolidin-4-one analogs as Mycobacterium tuberculosis DNA gyrase inhibitors
Shankar Alegaon
Future Journal of Pharmaceutical Sciences
View PDFchevron_right
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives
ANROOP NAIR
Antibiotics
View PDFchevron_right
C-1 Substituted isoquinolines potentiate the antimycobacterial activity of rifampicin and ethambutol
Helen Hailes
Frontiers in Antibiotics
View PDFchevron_right
Ring-substituted 8-hydroxyquinoline-2-carboxanilides as potential antimycobacterial agents
Tibor Liptaj
Bioorganic & Medicinal Chemistry, 2015
View PDFchevron_right
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis
Maria Cristiano
Journal of medicinal chemistry, 2017
View PDFchevron_right
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
Rosaria Luciani
ACS Chemical Biology, 2015
View PDFchevron_right
Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis
Maria de Lurdes Cristiano
Journal of Medicinal Chemistry, 2017
View PDFchevron_right
Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives
Rajitha Bollu
Chemical Biology & Drug Design, 2018
View PDFchevron_right
Discovery of Schaeffer’s Acid Analogues as Lead Structures of Mycobacterium tuberculosis Type II Dehydroquinase Using a Rational Drug Design Approach
Tom Blundell
ChemMedChem, 2012
View PDFchevron_right
Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase
Juan Guzman
The Journal of antimicrobial chemotherapy, 2015
View PDFchevron_right
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis
Silvia Pérez-silanes
Bioorganic & Medicinal Chemistry Letters, 2016
View PDFchevron_right
TMC207: the first compound of a new class of potent anti-tuberculosis drugs
Kelly Dooley
Future Microbiology, 2010
View PDFchevron_right
Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation
Kshitij Kr Patel
Bioorganic Chemistry, 2020
View PDFchevron_right
Structural investigation of inhibitor designs targeting 3-dehydroquinate dehydratase from the shikimate pathway of Mycobacterium tuberculosis
Tom Blundell
Biochemical Journal, 2011
View PDFchevron_right
A Prodrug Approach for Improving Antituberculosis Activity of Potent Mycobacterium tuberculosis Type II Dehydroquinase Inhibitors
Antonio L Llamas-Saiz
Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Mycobacterium tuberculosis Gyrase Inhibitors as a New Class of Antitubercular Drugs
Alfonso Mendoza
Antimicrobial Agents and Chemotherapy, 2015
View PDFchevron_right